PRICE MICHAEL DENNIS (Chief Financial Officer) reported 1 transaction at NOVELION THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/26/2019ACC: 0001104659-19-051596
Officer· Chief Financial Officer
Since Nov 2018
-3.93K
Net shares
Net seller
$3.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
3.93K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.93K
Price / share
$0.76
Trade value
$2.98K
% of position
21.8%
9/24/2019
18.04K→14.11K
Total
Net shares
−3.93K
Net value
-$2.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/24/2019 | F · Tax Withholding | −3.93K | $0.76 | $2.98K | 21.8% | 18.04K | 14.11K |
| Total | −3.93K | -$2.98K | ||||||
Derivative Transactions0
No derivative transactions reported